Seaview Investment Managers’s AbbVie ABBV Stock Holding History

Seaview Investment Managers’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.51M	Sell	37,773 -1,863	-5%	-$401K	2.84%	19
2026 Q1	$8.62M	Buy	39,636 +5,119	+15%	+$1.14M	3.11%	14
2025 Q4	$7.89M	Buy	+34,517	New	+$7.86M	2.97%	24
2025 Q3	–	Sell	-6,787	Closed	-$1.26M	–	76
2025 Q2	$1.26M	Buy	6,787 +330	+5%	+$61.3K	0.27%	48
2025 Q1	$1.35M	Buy	6,457 +5,069	+365%	+$985K	0.33%	37
2024 Q4	$247K	Buy	+1,388	New	+$255K	0.07%	87
2022 Q3	–	Sell	-2,183	Closed	-$334K	–	90
2022 Q2	$334K	Sell	2,183 -45,707	-95%	-$6.98M	0.15%	68
2022 Q1	$7.76M	Buy	+47,890	New	+$6.96M	2.59%	13
2021 Q3	–	Sell	-45,960	Closed	-$5.18M	–	90
2021 Q2	$5.18M	Buy	45,960 +11,232	+32%	+$1.26M	2.64%	13
2021 Q1	$3.76M	Sell	34,728 -663	-2%	-$70.9K	2.75%	14
2020 Q4	$3.79M	Sell	35,391 -13	-0%	-$1.25K	2.66%	14
2020 Q3	$3.01M	Buy	+35,404	New	+$3.33M	2.77%	24

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Seaview Investment Managers's ABBV Position: Q2 2026 in Review

Seaview Investment Managers reduced its AbbVie (ABBV) stake by 4.7% in Q2 2026, selling an estimated $401K and leaving 37,773 shares worth $9.51M. The position accounts for 2.84% of the portfolio, ranked #19.

Seaview Investment Managers first reported a position in ABBV in Q3 2020 and has held it in 12 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Seaview Investment Managers held 37,773 shares of AbbVie worth $9.51M as of Q2 2026.
Seaview Investment Managers sold 1,863 AbbVie shares in Q2 2026, an estimated $401K.
AbbVie made up 2.84% of Seaview Investment Managers's portfolio in Q2 2026, its #19 holding.
Seaview Investment Managers first reported a position in AbbVie in Q3 2020 and has held it in 12 quarters since.
4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Seaview Investment Managers's 13F filing for Q2 2026, filed 14 Jul 2026.